{"pmid":32270500,"title":"Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.","text":["Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.","Since December, 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has spread to a lot of countries worldwide(1,2) . On Jan 30, 2020, the World Health Organization (WHO) had declared that the outbreak of COVID-19 is a Public Health Emergency of International Concern. On March 11, 2020, the spread of COVID-19 was declared a pandemic by the WHO. This article is protected by copyright. All rights reserved.","J Med Virol","Chen, Dexiong","Li, Yueping","Deng, Xilong","Huang, Huanliang","Ou, Xueting","Lin, Yuebao","Pan, Xingfei","Lei, Chunliang","32270500"],"abstract":["Since December, 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has spread to a lot of countries worldwide(1,2) . On Jan 30, 2020, the World Health Organization (WHO) had declared that the outbreak of COVID-19 is a Public Health Emergency of International Concern. On March 11, 2020, the spread of COVID-19 was declared a pandemic by the WHO. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Chen, Dexiong","Li, Yueping","Deng, Xilong","Huang, Huanliang","Ou, Xueting","Lin, Yuebao","Pan, Xingfei","Lei, Chunliang"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270500","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25849","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663620082974064640,"score":7.9164424,"similar":[{"pmid":32222992,"title":"Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia.","text":["Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia.","Coronavirus Disease 2019 (COVID-19) is a newly emerging infectious disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). After its first occurrence in Wuhan of China from December 2019, COVID-19 rapidly spread around the world. According to the World Health Organization (WHO) statement on March 13, 2020, there had been over 132,500 confirmed cases globally. Nevertheless, the case reports of children are rare, which result in the lack of evidence for preventing and controlling of children's infection. Here, we report 3 cases of SARS-CoV-2 infected children diagnosed from February 3 to February 17, 2020 in Tianjin, China. All of these three cases experienced mild illness and recovered soon after treatment, with the nucleic acid of throat swab turning negative within 14, 11, 7 days after diagnosis respectively. However, after been discharged, all the three cases were tested SARS-CoV-2 positive in the stool samples within 10 days, in spite of their remained negative nucleic acid in throat swab specimens. Therefore, it is necessary to be aware of the possibility of fecal-oral transmission of SARS-CoV-2 infection, especially for children cases. This article is protected by copyright. All rights reserved.","J Med Virol","Zhang, Tongqiang","Cui, Xiaojian","Zhao, Xue","Wang, Jinhu","Zheng, Jiafeng","Zheng, Guifen","Guo, Wei","Cai, Chunquan","He, Sijia","Xu, Yongsheng","32222992"],"abstract":["Coronavirus Disease 2019 (COVID-19) is a newly emerging infectious disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). After its first occurrence in Wuhan of China from December 2019, COVID-19 rapidly spread around the world. According to the World Health Organization (WHO) statement on March 13, 2020, there had been over 132,500 confirmed cases globally. Nevertheless, the case reports of children are rare, which result in the lack of evidence for preventing and controlling of children's infection. Here, we report 3 cases of SARS-CoV-2 infected children diagnosed from February 3 to February 17, 2020 in Tianjin, China. All of these three cases experienced mild illness and recovered soon after treatment, with the nucleic acid of throat swab turning negative within 14, 11, 7 days after diagnosis respectively. However, after been discharged, all the three cases were tested SARS-CoV-2 positive in the stool samples within 10 days, in spite of their remained negative nucleic acid in throat swab specimens. Therefore, it is necessary to be aware of the possibility of fecal-oral transmission of SARS-CoV-2 infection, especially for children cases. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zhang, Tongqiang","Cui, Xiaojian","Zhao, Xue","Wang, Jinhu","Zheng, Jiafeng","Zheng, Guifen","Guo, Wei","Cai, Chunquan","He, Sijia","Xu, Yongsheng"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32222992","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25795","keywords":["COVID-19","Children","Clinical characteristics","SARS-CoV-2"],"source":"PubMed","locations":["Feces","Pneumonia","Wuhan","China","Tianjin"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1663352135189790724,"score":152.30672},{"pmid":32270568,"title":"Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019-2020: Sichuan Cancer Hospital.","text":["Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019-2020: Sichuan Cancer Hospital.","Since December 2019, a number of patients with novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei Province, China. NCP has rapidly spread to other provinces and cities in China and other countries in the world. Due to the rapid increase in reported cases in China and around the world, on January 30, 2020, the World Health Organization (WHO) Emergency Committee announced that NCP is a Public Health Emergency of International Concern (PHEIC). However, there are relatively few suggestions and measures for tumor patients, especially patients with head and neck tumors. This article summarizes the prevention and control of disease in our medical institution to provide a reference for front-line head and neck surgeons. This article is protected by copyright. All rights reserved.","Head Neck","Cai, Yong-Cong","Wang, Wei","Li, Chao","Zeng, Din-Fen","Zhou, Yu-Qiu","Sun, Rong-Hao","Jiang, Hua","Guo, Hui","Wang, Shao-Xin","Jiang, Jian","32270568"],"abstract":["Since December 2019, a number of patients with novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei Province, China. NCP has rapidly spread to other provinces and cities in China and other countries in the world. Due to the rapid increase in reported cases in China and around the world, on January 30, 2020, the World Health Organization (WHO) Emergency Committee announced that NCP is a Public Health Emergency of International Concern (PHEIC). However, there are relatively few suggestions and measures for tumor patients, especially patients with head and neck tumors. This article summarizes the prevention and control of disease in our medical institution to provide a reference for front-line head and neck surgeons. This article is protected by copyright. All rights reserved."],"journal":"Head Neck","authors":["Cai, Yong-Cong","Wang, Wei","Li, Chao","Zeng, Din-Fen","Zhou, Yu-Qiu","Sun, Rong-Hao","Jiang, Hua","Guo, Hui","Wang, Shao-Xin","Jiang, Jian"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270568","week":"202015|Apr 06 - Apr 12","doi":"10.1002/hed.26161","keywords":["2019 novel coronavirus diseases","head and neck tumor","infectious diseases","medical protection"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663620083105136641,"score":132.84818},{"pmid":32270498,"title":"Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.","text":["Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.","A novel coronavirus disease (COVID-19) was first identified in Wuhan, China in December 2019 [1], and after a few weeks, the World Health Organization (WHO) declared the outbreak as a global pandemic [2]. Scientifically, the virus was named \"severe acute respiratory syndrome (SARS-2) coronavirus\" [3]. High-level endemic transmissions occurred in several countries, and while yet very limited, have spread in certain regions of the globe, particularly in Africa [4]. This article is protected by copyright. All rights reserved.","J Med Virol","Ahmed, Anwar E","32270498"],"abstract":["A novel coronavirus disease (COVID-19) was first identified in Wuhan, China in December 2019 [1], and after a few weeks, the World Health Organization (WHO) declared the outbreak as a global pandemic [2]. Scientifically, the virus was named \"severe acute respiratory syndrome (SARS-2) coronavirus\" [3]. High-level endemic transmissions occurred in several countries, and while yet very limited, have spread in certain regions of the globe, particularly in Africa [4]. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Ahmed, Anwar E"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270498","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25852","source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1663620082993987584,"score":130.55879},{"pmid":32190904,"title":"Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.","text":["Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.","At present, Coronavirus Disease 2019 (COVID-19) is rampaging around the world. However, asymptomatic carriers intensified the difficulty of prevention and management. Here we reported the screening, clinical feathers, and treatment process of a family cluster involving three COVID-19 patients. The discovery of the first asymptomatic carrier in this family cluster depends on the repeated and comprehensive epidemiological investigation by disease control experts. In addition, the combination of multiple detection methods can help clinicians find asymptomatic carriers as early as possible. In conclusion, the prevention and control experience of this family cluster showed that comprehensive rigorous epidemiological investigation and combination of multiple detection methods were of great value for the detection of hidden asymptomatic carriers. This article is protected by copyright. All rights reserved.","J Med Virol","Lu, Shubiao","Lin, Jinsong","Zhang, Zhiqiao","Xiao, Liping","Jiang, Zhijian","Chen, Jia","Hu, Chongjing","Luo, Shi","32190904"],"abstract":["At present, Coronavirus Disease 2019 (COVID-19) is rampaging around the world. However, asymptomatic carriers intensified the difficulty of prevention and management. Here we reported the screening, clinical feathers, and treatment process of a family cluster involving three COVID-19 patients. The discovery of the first asymptomatic carrier in this family cluster depends on the repeated and comprehensive epidemiological investigation by disease control experts. In addition, the combination of multiple detection methods can help clinicians find asymptomatic carriers as early as possible. In conclusion, the prevention and control experience of this family cluster showed that comprehensive rigorous epidemiological investigation and combination of multiple detection methods were of great value for the detection of hidden asymptomatic carriers. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lu, Shubiao","Lin, Jinsong","Zhang, Zhiqiao","Xiao, Liping","Jiang, Zhijian","Chen, Jia","Hu, Chongjing","Luo, Shi"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32190904","week":"202012|Mar 16 - Mar 22","doi":"10.1002/jmv.25776","keywords":["COVID-19","Family cluster","Incubation period"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663352133771067392,"score":130.42389},{"pmid":32243668,"title":"A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.","text":["A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.","The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. This article is protected by copyright. All rights reserved.","Oncologist","Al-Shamsi, Humaid O","Alhazzani, Waleed","Alhuraiji, Ahmad","Coomes, Eric A","Chemaly, Roy F","Almuhanna, Meshari","Wolff, Robert","Nuhad, Ibrahim K","Chua, Melvin L K","Hotte, Sebastien J","Meyers, Brandon M","Elfiki, Tarek","Curigliano, Giuseppe","Eng, Cathy","Grothey, Axel","Xie, Conghua","32243668"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. This article is protected by copyright. All rights reserved."],"journal":"Oncologist","authors":["Al-Shamsi, Humaid O","Alhazzani, Waleed","Alhuraiji, Ahmad","Coomes, Eric A","Chemaly, Roy F","Almuhanna, Meshari","Wolff, Robert","Nuhad, Ibrahim K","Chua, Melvin L K","Hotte, Sebastien J","Meyers, Brandon M","Elfiki, Tarek","Curigliano, Giuseppe","Eng, Cathy","Grothey, Axel","Xie, Conghua"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243668","week":"202014|Mar 30 - Apr 05","doi":"10.1634/theoncologist.2020-0213","keywords":["COVID-19","Coronavirus","Influenza","Neoplasm","Pandemic","SARS-CoV-2"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352135702544384,"score":130.0102}]}